Cagrilintide 5mg

Cagrilintide 5mg

SKU: PTX-CAGRILINTIDE-5MG Category:

Additional information

Strength

5 mg

Reviews

There are no reviews yet.

Be the first to review “Cagrilintide 5mg”

Your email address will not be published. Required fields are marked *

Cagrilintide is a long-acting amylin analog researched for satiety signaling, appetite control, food-intake reduction, and weight-management pathways. It is often studied alone and in combination with GLP-1 receptor agonists.

Mimics amylin-related signaling associated with meal termination, satiety, and reduced energy intake. In combination research, amylin and GLP-1 pathways are studied for complementary effects on appetite and body weight.

Clinical research has reported significant body-weight reductions in adults with overweight or obesity. Additional trials have examined cagrilintide with semaglutide (CagriSema) for combined metabolic and weight-management research.

  • Once-weekly cagrilintide for weight management — The Lancet/PubMed, 2021
  • Coadministered cagrilintide and semaglutide — The Lancet/PubMed, 2023
FormLyophilized powder
Purity≥ 99% (HPLC)
Strength5 mg
StorageRefrigerated, 2–8 °C
ClassificationResearch Use Only
This product is intended strictly for laboratory research purposes only. It is not for human consumption, therapeutic use, diagnostic use, or veterinary use. These statements have not been evaluated by the U.S. Food and Drug Administration. Researchers are solely responsible for proper handling, storage, and use in accordance with applicable laws.

Related products